PT2883966T - Impressão digital de mirna no diagnóstico de cancro do pulmão - Google Patents

Impressão digital de mirna no diagnóstico de cancro do pulmão

Info

Publication number
PT2883966T
PT2883966T PT141963108T PT14196310T PT2883966T PT 2883966 T PT2883966 T PT 2883966T PT 141963108 T PT141963108 T PT 141963108T PT 14196310 T PT14196310 T PT 14196310T PT 2883966 T PT2883966 T PT 2883966T
Authority
PT
Portugal
Prior art keywords
diagnosis
lung cancer
mirna fingerprint
mirna
fingerprint
Prior art date
Application number
PT141963108T
Other languages
English (en)
Inventor
Keller Andreas
Meese Eckart
Borries Anne
Beier Markus
Original Assignee
Hummingbird Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hummingbird Diagnostics Gmbh filed Critical Hummingbird Diagnostics Gmbh
Publication of PT2883966T publication Critical patent/PT2883966T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT141963108T 2009-06-05 2010-06-07 Impressão digital de mirna no diagnóstico de cancro do pulmão PT2883966T (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18445209P 2009-06-05 2009-06-05
US21397109P 2009-08-03 2009-08-03
US28752109P 2009-12-17 2009-12-17
EP09015668A EP2336353A1 (en) 2009-12-17 2009-12-17 miRNA fingerprints in the diagnosis of diseases

Publications (1)

Publication Number Publication Date
PT2883966T true PT2883966T (pt) 2017-10-16

Family

ID=42470815

Family Applications (1)

Application Number Title Priority Date Filing Date
PT141963108T PT2883966T (pt) 2009-06-05 2010-06-07 Impressão digital de mirna no diagnóstico de cancro do pulmão

Country Status (10)

Country Link
US (7) US9187785B2 (pt)
EP (9) EP2336353A1 (pt)
DK (1) DK2883966T3 (pt)
ES (1) ES2642395T3 (pt)
HK (1) HK1252674A1 (pt)
HU (1) HUE035009T2 (pt)
NO (1) NO2883966T3 (pt)
PL (1) PL2883966T3 (pt)
PT (1) PT2883966T (pt)
WO (3) WO2010139812A1 (pt)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8415096B2 (en) 2007-05-23 2013-04-09 University Of South Florida Micro-RNAs modulating immunity and inflammation
WO2010099342A2 (en) * 2009-02-25 2010-09-02 Cepheid Methods of detecting lung cancer
WO2010124284A1 (en) * 2009-04-24 2010-10-28 Hemant Virkar Methods for mapping data into lower dimensions
EP2336353A1 (en) * 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases
WO2011076144A1 (en) * 2009-12-24 2011-06-30 Fudan University Compositions and methods for microrna expession profiling in plasma of lung cancer
WO2011163214A2 (en) * 2010-06-21 2011-12-29 Diogenix, Inc. Microrna profiles for evaluating multiple sclerosis
BR112013001136B1 (pt) 2010-07-16 2020-12-15 Stichting Vumc Processos de análise para a presença de um marcador de câncer, do estágio da doença ou da eficácia de um tratamento de câncer, e dispositivo para diagnóstico de câncer
US20120107825A1 (en) * 2010-11-01 2012-05-03 Winger Edward E Methods and compositions for assessing patients with reproductive failure using immune cell-derived microrna
EP2655660A2 (en) * 2010-12-22 2013-10-30 Herlev Hospital Microrna for diagnosis of pancreatic cancer
CN102127548A (zh) * 2010-12-28 2011-07-20 浙江大学 单链非编码MicroRNA二及其用途
EP2505663A1 (en) * 2011-03-30 2012-10-03 IFOM Fondazione Istituto Firc di Oncologia Molecolare A method to identify asymptomatic high-risk individuals with early stage lung cancer by means of detecting miRNAs in biologic fluids
AU2012211272A1 (en) 2011-01-26 2013-08-15 Cepheid Methods of detecting lung cancer
US20120214682A1 (en) * 2011-01-28 2012-08-23 Bigwood Douglas W Microrna signatures indicative of immunomodulating therapy for multiple sclerosis
EP2668288B1 (en) * 2011-01-28 2016-01-20 Comprehensive Biomarker Center GmbH Complex mirna sets as novel biomarkers for lung diseases
CN102643812B (zh) * 2011-02-18 2016-02-10 中国科学院上海药物研究所 人miR-1227的反义寡聚核苷酸及其应用
CA2830461C (en) * 2011-03-18 2021-06-29 Thomas Wurdinger A method of analysing a blood sample of a subject for the presence of a disease marker
US20140031258A1 (en) * 2011-03-28 2014-01-30 The Johns Hopkins University Serum-based mirna microarray and its use in diagnosis and treatment of barrett's esophagus (be) and esophageal adenocarcinoma (eac)
JP6011945B2 (ja) * 2011-05-20 2016-10-25 公一 中城 マイクロｒｎａ又はその発現系を含む組成物
WO2012168448A2 (en) * 2011-06-08 2012-12-13 Febit Holding Gmbh Complex sets of mirnas as non-invasive biomarkers for dilated cardiomyopathy
CN102851282B (zh) * 2011-06-30 2014-10-08 上海市肿瘤研究所 用于区分原发性肺癌与癌旁组织的microRNA标志物
CN102250904B (zh) * 2011-07-13 2013-11-13 中国科学技术大学 一种预防和/或治疗黑色素瘤的药物
DE102011108254A1 (de) * 2011-07-22 2013-01-24 RUHR-UNIVERSITäT BOCHUM Pantumormarker
US20130059753A1 (en) * 2011-09-01 2013-03-07 Holy and Undivided Trinity of Queen Elizabeth, near Dublin Global Analysis of Serum microRNAs as Potential Biomarkers for Lung Adenocarcinoma
EP2578696A1 (en) * 2011-10-06 2013-04-10 febit holding GmbH MiRNAs as non-invasive biomarkers for diagnosis
GB2536374B (en) 2011-10-19 2016-10-26 Council Scient Ind Res Biomarkers useful for detection of types, grades and stages of human breast cancer
NO3051026T3 (pt) * 2011-10-21 2018-07-28
US9745578B2 (en) 2011-11-30 2017-08-29 Cedars-Sinai Medical Center Targeting microRNA miR-409-3P to treat prostate cancer
US9753043B2 (en) 2011-12-18 2017-09-05 20/20 Genesystems, Inc. Methods and algorithms for aiding in the detection of cancer
US9447471B2 (en) * 2011-12-29 2016-09-20 Quest Diagnostics Investments Incorporated Microrna profiling for diagnosis of dysplastic nevi and melanoma
WO2013106766A2 (en) * 2012-01-13 2013-07-18 The Research Foundation Of State University Of New York THERAPEUTIC INDICATIONS OF miR-1291
US9353413B2 (en) * 2012-01-13 2016-05-31 Micromedmark Biotech Co., Ltd. Internal reference genes for microRNAs normalization and uses thereof
EP3360977A3 (en) * 2012-03-07 2018-10-10 Hummingbird Diagnostics GmbH Mi-rna based treatment monitoring in multiple sclerosis
WO2013131567A1 (en) * 2012-03-07 2013-09-12 Febit Holding Gmbh Mirna based treatment monitoring in multiple sclerosis
CN103372218B (zh) * 2012-04-19 2016-05-04 中国科学院上海生命科学研究院 自身免疫性疾病相关的microRNA及其应用
EP2657348B1 (en) * 2012-04-27 2017-11-15 Siemens Aktiengesellschaft Diagnostic miRNA profiles in multiple sclerosis
US8846316B2 (en) 2012-04-30 2014-09-30 Industrial Technology Research Institute Biomarker for human liver cancer
WO2013173500A2 (en) * 2012-05-15 2013-11-21 New York University Method for predicting recurrence of melanoma using mirna alterations
CN102676526B (zh) * 2012-05-16 2013-05-29 北京旷博生物技术有限公司 乳腺癌分子标志物miR-30c-1-3p
EP2687607B1 (en) 2012-07-19 2015-03-04 St. Josef- und St. Elisabeth-Hospital GmbH MicroRNA profiles in the diagnosis of multiple sclerosis
US20150232939A1 (en) * 2012-10-26 2015-08-20 Gabriella Sozzi Micro-rna biomarkers for haemolysis and methods of using same
CN103045597B (zh) * 2013-01-11 2014-06-11 南京大学 微小核苷酸hsa-miR-1909及其应用
CN103305602A (zh) * 2013-03-08 2013-09-18 深圳市人民医院 一种基于液相芯片检测痰液microRNAs用于早期肺癌诊断的方法
KR20150069375A (ko) * 2013-12-13 2015-06-23 연세대학교 산학협력단 줄기세포로부터 연골세포로의 분화 촉진용 조성물
EP3760741A1 (en) * 2013-12-19 2021-01-06 Hummingbird Diagnostics GmbH Mirnas as non-invasive biomarkers for parkinson's disease
US20150176076A1 (en) * 2013-12-20 2015-06-25 Acetylon Pharmaceuticals, Inc. Histone deacetylase 6 (hdac6) biomarkers in multiple myeloma
PL406989A1 (pl) 2014-01-29 2015-08-03 Gdański Uniwersytet Medyczny Profil mikro RNA we krwi jako test wykrywania raka płuca
KR20230136701A (ko) 2014-06-18 2023-09-26 도레이 카부시키가이샤 폐암의 검출 키트 또는 디바이스 및 검출 방법
WO2016094330A2 (en) 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
JP6974182B2 (ja) * 2015-03-04 2021-12-01 ハミングバード・ダイアグノスティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングHummingbird Diagnostics GmbH 健康のサイン
PL411561A1 (pl) 2015-03-13 2016-09-26 Gdański Uniwersytet Medyczny Profil mikroRNA skojarzony z profilem markerów białkowych krwi jako test wykrywania raka płuca
CN104789683B (zh) * 2015-05-01 2018-08-28 北京博奥医学检验所有限公司 用于诊治癌转移的生物标志物及其用途
EP3292213A1 (en) 2015-05-04 2018-03-14 Academisch Medisch Centrum Biomarkers for the detection of aspirin insensitivity
KR102552776B1 (ko) * 2015-11-30 2023-07-10 (주)아모레퍼시픽 miRNA를 포함하는 흑색종 전이 억제용 조성물
EP3184645A1 (de) 2015-12-22 2017-06-28 Siemens Healthcare GmbH Diagnostische mirna signaturen in ms und cis patienten
WO2017110687A1 (ja) * 2015-12-24 2017-06-29 公益財団法人がん研究会 ｍｉＲＮＡにより肺癌の原因を特定する方法、マーカー、検出キット、及び治療薬をスクリーニングするための方法
CA3019550A1 (en) * 2016-04-01 2017-10-05 Toray Industries, Inc. Kit or device for detecting malignant brain tumor and method for detecting same
US20210095342A1 (en) * 2016-05-09 2021-04-01 The Children's Hospital Of Philadelphia Functional targets of mir-6891-5p & applications thereof
WO2018041726A1 (en) 2016-08-27 2018-03-08 Academisch Medisch Centrum Biomarkers for determining the presence of an unstable atherosclerotic plaque
KR101721811B1 (ko) * 2016-12-28 2017-03-30 경북대학교 산학협력단 ｍｉｃｒｏＲＮＡ－30ｂ, ｍｉｃｒｏＲＮＡ－133ａ 또는 ｍｉｃｒｏＲＮＡ－202－5ｐ의 억제제를 포함하는 항암용 약학적 조성물
US10733214B2 (en) 2017-03-20 2020-08-04 International Business Machines Corporation Analyzing metagenomics data
EP3607066A4 (en) * 2017-04-06 2021-05-19 The United States Government as Represented by the Department of Veterans Affairs PROCEDURE FOR DETECTION OF LUNG CANCER
WO2019000017A1 (en) * 2017-06-29 2019-01-03 The University Of Sydney INTRACELLULAR MICRO-RNA SIGNATURES OF INSULIN-PRODUCING CELLS
CA3068585A1 (en) 2017-06-29 2019-01-03 Toray Industries, Inc. Kit, device, and method for detecting lung cancer
JP7354099B2 (ja) * 2017-10-03 2023-10-02 ジェネシーク ピーティーワイ リミテッド マイクロｒｎａ遺伝子発現を使用して黒色腫を診断し、病期分類し、モニタリングする方法
CN109706146B (zh) * 2017-10-25 2023-06-06 上海翔琼生物技术有限公司 小rna组成的指纹图谱在人的癌性胸腔积液诊断和治疗中的应用
CN109288361B (zh) * 2018-10-10 2020-05-12 童小鸾 一种服装机械用的衣架
CN109207599A (zh) * 2018-11-12 2019-01-15 觅瑞（杭州）生物科技有限公司 一种用于非小细胞肺癌诊断的外周血miRNA标志物
CN109224076B (zh) * 2018-11-14 2021-11-19 苏州吉玛基因股份有限公司 与肺癌诊疗相关的基因miR-140-3P及其mimics和应用
CN111197070A (zh) * 2018-11-16 2020-05-26 南京迈西可生物科技有限公司 鉴定rna分子中2`-o-甲基化修饰的方法及其应用
US11948684B2 (en) * 2019-06-20 2024-04-02 Latha Chakravarthy Diagnostic process for disease detection using gene expression based multi layer PCA classifier
WO2021041556A1 (en) * 2019-08-26 2021-03-04 Liquid Lung Dx Biomarkers for the diagnosis of lung cancers
JP7473941B2 (ja) 2019-11-07 2024-04-24 学校法人産業医科大学 中皮腫の診断補助方法及び診断用キット
KR102288359B1 (ko) * 2019-12-06 2021-08-10 주식회사 레피겐엠디 면역력 감소에 의한 질병의 발병 위험 예측용 다중 유전자 마커 및 이를 이용한 질병의 발병 위험 예측 방법
EP3862442A3 (en) * 2020-02-04 2021-10-27 Artemisia S.p.A. Method for the early diagnosis of cancer by means of ddpcr analysis of mirna in liquid biopsy
EP3862441A3 (en) * 2020-02-04 2021-10-27 Artemisia S.p.A. Method for the early diagnosis of cancer by means of ddpcr analysis of mirna and protein markers in liquid biopsy
CN112501295B (zh) * 2020-12-01 2023-03-31 上海米然生物科技有限公司 miRNA组合、含其的试剂盒及在肺癌诊断中的应用
CN111793692A (zh) * 2020-08-04 2020-10-20 中国科学院昆明动物研究所 一种特征miRNA表达谱组合及肺鳞癌早期预测方法
US20220073992A1 (en) * 2020-11-24 2022-03-10 Hossein Abdul Tehrani Abdul Tehrani Diagnosis of chronic kidney disease (ckd) and its subgroups
RU2755651C1 (ru) * 2020-12-21 2021-09-17 федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации (ФГБУ «НМИЦ им. ак. Е.Н. Мешалкина» Минздрава России) Аналитическая система для диагностики рака лёгкого при помощи свободных и ассоциированных с клетками крови циркулирующих микроРНК
WO2022266083A2 (en) * 2021-06-15 2022-12-22 Modernatx, Inc. Engineered polynucleotides for cell-type or microenvironment-specific expression
WO2024002599A1 (en) * 2022-06-28 2024-01-04 Hummingbird Diagnostics Gmbh Novel signatures for lung cancer detection
WO2024009221A1 (en) * 2022-07-04 2024-01-11 Artificial Intelligence Expert Srl Method and system for multi-cancer management in subject
CN115820858B (zh) * 2022-11-18 2023-06-20 昆明医科大学第一附属医院 一种血清在制备云南宣威肺癌诊断药物中的应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020168640A1 (en) 2001-02-22 2002-11-14 Min Li Biochips comprising nucleic acid/protein conjugates
US20030186248A1 (en) * 2002-03-29 2003-10-02 Erlander Mark G. Interpreting cytological specimens via molecular histological signatures
EP1784501B1 (en) * 2004-05-14 2015-11-18 Rosetta Genomics Ltd VIRAL AND VIRUS ASSOCIATED MicroRNAS AND USES THEREOF
WO2005118806A2 (en) * 2004-05-28 2005-12-15 Ambion, Inc. METHODS AND COMPOSITIONS INVOLVING MicroRNA
US20060019258A1 (en) 2004-07-20 2006-01-26 Illumina, Inc. Methods and compositions for detection of small interfering RNA and micro-RNA
WO2007081720A2 (en) * 2006-01-05 2007-07-19 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
EP2145001A2 (en) * 2006-09-19 2010-01-20 Asuragen, Inc. Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
CA2669600A1 (en) * 2006-11-13 2008-05-29 Source Precision Medicine, Inc. D/B/A Source Mdx Gene expression profiling for identification, monitoring, and treatment of lung cancer
US20120064520A1 (en) 2007-03-01 2012-03-15 Ranit Aharonov Diagnosis and prognosis of various types of cancers
US20100178653A1 (en) 2007-03-27 2010-07-15 Rosetta Genomics Ltd. Gene expression signature for classification of cancers
WO2009025790A1 (en) 2007-08-17 2009-02-26 Catalyst Assets Llc Diagnostic and prognostic use of human bladder cancer-associated micro rnas
WO2009033185A1 (en) * 2007-09-06 2009-03-12 University Of Massachusetts Virus-specific mirna signatures for diagnosis and therapeutic treatment of viral infection
BRPI0816852A2 (pt) * 2007-09-14 2017-06-06 Univ Ohio State Res Found método de diagnosticar ou prognosticar doença ou desordem em sujeito, biomarcador, método para determinar e/ou prever se sujeito tem diferenciação da desordem, biomarcador para desordem pulmonar, método para diagnosticar se sujeito tem, ou está em risco de desenvolver doença ou desordem, método de inibir a proliferação de doença ou desordem e método para identificar agente terapêutico do câncer.
US8361714B2 (en) * 2007-09-14 2013-01-29 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
KR101672057B1 (ko) 2007-10-31 2016-11-02 로세타 제노믹스 리미티드 마이크로―ＲＮＡ／ｍｉＲＮＡ 의 감별 검출을 이용한 특정 암에 대한 진단 및 예후
CN101424640B (zh) 2007-11-02 2012-07-25 江苏命码生物科技有限公司 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法
WO2009070653A1 (en) * 2007-11-30 2009-06-04 The Ohio State University Research Foundation Microrna expression profiling and targeting in peripheral blood in lung cancer
WO2009099905A2 (en) * 2008-02-01 2009-08-13 Memorial Health Inc. Molecular signatures and biomarkers associated with melanoma and methods of use thereof
AU2009219203B2 (en) * 2008-02-28 2014-04-03 The Ohio State University Research Foundation MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia (AML) and uses thereof
WO2009143379A2 (en) * 2008-05-21 2009-11-26 Fred Hutchinson Cancer Research Center Use of extracellular rna to measure disease
US20110107440A1 (en) 2008-06-04 2011-05-05 Andor Pivarcsi Skin cancer associated micrornas
US9068974B2 (en) * 2008-11-08 2015-06-30 The Wistar Institute Of Anatomy And Biology Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers
CN101475984A (zh) 2008-12-15 2009-07-08 江苏命码生物科技有限公司 一种非小细胞肺癌检测标记物及其检测方法、相关生物芯片和试剂盒
EP2336353A1 (en) * 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases

Also Published As

Publication number Publication date
PL2883966T3 (pl) 2018-01-31
EP2883966A1 (en) 2015-06-17
US10000810B2 (en) 2018-06-19
EP3296406A2 (en) 2018-03-21
EP3683320A2 (en) 2020-07-22
EP2438187A1 (en) 2012-04-11
EP3184651B1 (en) 2023-08-16
US20160053325A1 (en) 2016-02-25
EP2883966B1 (en) 2017-08-09
US20120157336A1 (en) 2012-06-21
US20120108462A1 (en) 2012-05-03
US9758827B2 (en) 2017-09-12
US20220042102A1 (en) 2022-02-10
US9702008B2 (en) 2017-07-11
HK1252674A1 (zh) 2019-05-31
US20120157337A1 (en) 2012-06-21
DK2883966T3 (en) 2017-10-16
EP2438188A1 (en) 2012-04-11
EP2438188B1 (en) 2016-09-21
EP3112479A1 (en) 2017-01-04
EP2438187B1 (en) 2017-03-22
EP2336353A1 (en) 2011-06-22
WO2010139812A1 (en) 2010-12-09
EP3184651A1 (en) 2017-06-28
US20180087111A1 (en) 2018-03-29
US9187785B2 (en) 2015-11-17
US20160076103A1 (en) 2016-03-17
US9194002B2 (en) 2015-11-24
EP3296406A3 (en) 2018-05-16
EP2438190A1 (en) 2012-04-11
HUE035009T2 (en) 2018-05-02
EP3296406B1 (en) 2020-01-15
WO2010139811A1 (en) 2010-12-09
WO2010139812A4 (en) 2011-03-10
EP2438190B1 (en) 2015-01-07
NO2883966T3 (pt) 2018-01-06
WO2010139810A1 (en) 2010-12-09
EP3683320A3 (en) 2020-10-21
ES2642395T3 (es) 2017-11-16

Similar Documents

Publication Publication Date Title
HK1252674A1 (zh) 在肺癌診斷中的mirna指紋
ZA201207574B (en) Phytocannabinoids in the treatment of cancer
IL223295A0 (en) Lung cancer biomarkers and uses thereof
HK1175476A1 (en) Cancer treatment
GB2478441B (en) Lung cancer biomarkers and uses thereof
EP2470897A4 (en) MICRO-RNA BIOMARKERS OF PULMONARY DISEASE
EP2401406A4 (en) METHODS OF DETECTING LUNG CANCER
GB0922085D0 (en) Cancer diagnosis and treatment
GB2467840B (en) Disease determination
IL264349B1 (en) Regimens containing neratinib for the treatment of cancer
HU0900819D0 (en) Lung tissue culture
EP2457092A4 (en) CANCER BIOMARKERS AND THEIR USE
GB0918392D0 (en) Diagnostic and therapeutic methods
EP2361317A4 (en) USE OF EIF3M FOR THE DIAGNOSIS AND TREATMENT OF CANCER
GB0901837D0 (en) Cancer diagnosis and treatment
GB0902537D0 (en) Improvememts in or relating to the creation of curved forms
EP2403341A4 (en) LUNGENKREBSBEHNDLUNG
GB0914738D0 (en) Inhalers
EP2473613A4 (en) KREBSAUSHUNGERUNGSTHERAPIE
GB201718726D0 (en) Phytocannabinoids in the treatment of cancer
EP2321641A4 (en) GENE METHYLATION IN THE DIAGNOSIS OF CANCER
GB0902538D0 (en) Improvvements in or relating to the creation of curved forms
GB0907098D0 (en) Cancer treatment and diagnosis
GB0811923D0 (en) Lung cancer diagnosis, prognistication and treatment
GB0807998D0 (en) Cancer diagnostic LIMD1